KIANE GOEBEL: Open Payments
NPI 1912186529 · FORSYTH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$367 in 19 payments from 10 companies in 2025. Trend: 2023 $149 · 2024 $0 · 2025 $367
Food & beverage: $367
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Otsuka America Pharmaceutical, Inc. | 4 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $47 |
| Abbott Laboratories | 2 | $43 |
| ABBVIE INC. | 2 | $35 |
| Globus Medical, Inc. | 1 | $32 |
| Lundbeck LLC | 1 | $22 |
| Viatris Specialty LLC | 1 | $19 |
| Novo Nordisk Inc | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
Products named: REXULTI, CAPLYTA, FARXIGA, VRAYLAR, Senza, ETERNA, YUPELRI, FREESTYLE LIBRE.
Industry payments across MO — which companies pay providers there.
